κ‐Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat

British Journal of Pharmacology

Volumn 93, Issue 3, 1988, Pages 553-560

  Leighton, G E ^a   Rodriguez, R E ^a   Hill, R G ^a   Hughes, J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; KAPPA OPIATE RECEPTOR; MORPHINE; N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZO[B]THIOPHENE 4 ACETAMIDE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE;

ANALGESIA; ANIMAL EXPERIMENT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; TAIL FLICK TEST;

ANALGESICS; ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MORPHINE; PAIN MEASUREMENT; RATS; RATS, INBRED STRAINS; RECEPTORS, OPIOID; RECEPTORS, OPIOID, KAPPA;

EID: 0023850632     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1988.tb10310.x     Document Type: Article

References (45)

1. Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla
2. Immunoreactive dynorphin in mammalian spinal cord and dorsal root ganglia
3. The action of kappa agonists on the nociceptive responses of neurones in the medullary dorsal horn of the anaesthetized rat
4. Dynorphin is a specific endogenous ligand of the K opioid receptor
5. Highly selective kappa opioid analgesics. Synthesis and structure‐activity relationships of novel N‐2‐amino‐cyclohexylaryl‐ and aryloxy‐acetamides
6. Dynorphin (1‐8) and dynorphin (1‐9) are ligands for the kappa‐subtype of opiate receptor
7. 5]enkephalin
8. A method for determining loss of pain sensation
9. Dynorphin‐related peptides cause motor dysfunction in the rat through a non‐opiate action
10. Multiple opiate receptors in primary afferent fibres
11. The effects of morphine‐ and nalorphine‐like drugs in the nondependent, morphine‐dependent and cyclazocine‐dependent chronic spinal dog
12. Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide
13. Differentiation of delta and delta receptor localization by light microscopic autoradiography
14. Kappa‐opiate receptors localized by autoradiography to deep layers of cerebral cortex: relation to sedative effects
15. Antinociceptive profile of dynorphin in the rat
16. Antinociception and paralysis induced by intrathecal dynorphin A
17. Intrathecal dynorphin induces antinociception and paralysis
18. On the central sites for the antinociceptive action of morphine and fentanyl
19. 3H]ethylketocyclazocine binding in rat central nervous system: lack of evidence for kappa receptors
20. Identification of two related pentapeptides from the brain with potent opiate agonist activity
21. Dynorphin interaction at the κ‐opiate site
22. Preparation of brain membranes containing a single type of opioid receptor highly selective for dynorphin
23. Comparative spinal action of dynorphin (1‐8), dynorphin (1‐13) and a kappa‐receptor agonist U50,488
24. Sites of analgesic action of dynorphin
25. 3H]U‐69593 a highly selective ligand for the opioid k receptor
26. Opiate receptor binding in primate spinal cord: distribution and changes after dorsal root section
27. Pharmacological profile of PD117302 a selective κ‐opioid agonist
28. Endogenous opioid peptides: Multiple agonists and receptors
29. The effects of morphine and nalorphine‐like drugs in the nondependent and morphine‐dependent chronic spinal dog
30. Sites of morphine induced analgesia in the primate brain: relation to pain pathways
31. Analgesic effects of mu, delta and kappa‐opiate agonists and, in particular, dynorphin at the spinal level
32. 3H‐ethylketocyclazocine binding sites in rat and guinea pig brain
33. In vivo evidence for spinal delta‐opiate receptor operated antinociception
34. In vivo studies on spinal opiate systems mediating antinociception. II. Pharmacological profiles suggesting a differential association with mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat
35. Characterization of dynorphin A induced antinociception at spinal level
36. Dynorphin A and related peptides administered intrathecally in the rat: A search for putative kappa opiate receptor activity
37. Multiple opiate binding sites in the rat spinal cord
38. A classification of opiate receptors that mediate antinociception in animals
39. Evaluation of the supraspinal analgesic activity and abuse liability of ethylketocyclazocine
40. U‐50,488H; a selective and structurally novel non‐mu (kappa) opioid agonist
41. Spinal analgesia: Comparison of the mu agonist morphine and the kappa agonist ethylketocyclazocine
42. Inhibitory effect of U50488 on suckling‐evoked oxytocin release is blocked by propranolol
43. Studies on the direct spinal action of narcotics in the production of analgesia in the rat
44. Chronic catheterization of the spinal subarachnoid space